Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transcription Factors Associated With IL-15 Cytokine Signaling During NK Cell Development
Xiang Wang, Xiaosu Zhao
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy
Shoubao Ma, Michael A. Caligiuri, Jianhua Yu
Trends in Immunology (2022) Vol. 43, Iss. 10, pp. 833-847
Open Access | Times Cited: 115
Cell–cell communication: new insights and clinical implications
Jimeng Su, Ying Song, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 46
The role of chronic low-grade inflammation in the development of sarcopenia: Advances in molecular mechanisms
Ying Cheng, Shangjin Lin, Ziyi Cao, et al.
International Immunopharmacology (2025) Vol. 147, pp. 114056-114056
Closed Access | Times Cited: 2
Interleukin 15 in Cell-Based Cancer Immunotherapy
Yang Zhou, Tiffany Husman, Xinjian Cen, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7311-7311
Open Access | Times Cited: 64
Targeting tissue-resident memory CD8+ T cells in the kidney is a potential therapeutic strategy to ameliorate podocyte injury and glomerulosclerosis
Liang Li, Wei Tang, Yan Zhang, et al.
Molecular Therapy (2022) Vol. 30, Iss. 8, pp. 2746-2759
Open Access | Times Cited: 44
Differential IL-12 signaling induces human natural killer cell activating receptor-mediated ligand-specific expansion
Avishai Shemesh, Harry Pickering, Kole T. Roybal, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 8
Open Access | Times Cited: 41
cellPLATO – an unsupervised method for identifying cell behaviour in heterogeneous cell trajectory data
Michael J. Shannon, Shira E. Eisman, Alan R. Lowe, et al.
Journal of Cell Science (2024) Vol. 137, Iss. 20
Open Access | Times Cited: 12
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets
Robin Reschke, Alexander Enk, Jessica C. Hassel
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6532-6532
Open Access | Times Cited: 11
Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcεRIγ expression
Avishai Shemesh, Yapeng Su, Daniel R. Calabrese, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 11
Open Access | Times Cited: 35
The role of interleukin-15 in the development and treatment of hematological malignancies
Paola Del Sindaco, Hritisha Pandey, Colleen Isabelle, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
ROS fine-tunes the function and fate of immune cells
Shiyu Liu, Benqi Huang, Jingdong Cao, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110069-110069
Closed Access | Times Cited: 19
IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside
Sogand Vahidi, Arefeh Zabeti Touchaei, Ali Akbar Samadani
International Immunopharmacology (2024) Vol. 133, pp. 112156-112156
Closed Access | Times Cited: 7
Exploring Immune Redox Modulation in Bacterial Infections: Insights into Thioredoxin-Mediated Interactions and Implications for Understanding Host–Pathogen Dynamics
Omer M. A. Dagah, Billton Bryson Silaa, Minghui Zhu, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 545-545
Open Access | Times Cited: 7
Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation
Thomas Yul Avery, Natalie Köhler, Robert Zeiser, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 27
Natural Killer Cells in the Malignant Niche of Multiple Myeloma
Ondrej Venglár, Julio Rodriguez Bagó, Benjamin Motais, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 23
Contribution of natural killer cells in innate immunity against colorectal cancer
Zeinab Ghazvinian, Shahrokh Abdolahi, Samaneh Tokhanbigli, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 15
The role and novel use of natural killer cells in graft-versus-leukemia reactions after allogeneic transplantation
Ashley Hadjis, Shannon R. McCurdy
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Immunometabolism: signaling pathways, homeostasis, and therapeutic targets
Rongrong Xu, Xiaobo He, Jia Xu, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 5
Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia
Anil Kumar, Adeleh Taghi Khani, Caroline Duault, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 5, pp. e006649-e006649
Open Access | Times Cited: 12
Lung cancer cell-intrinsic IL-15 promotes cell migration and sensitizes murine lung tumors to anti-PD-L1 therapy
Shaojie Hu, Kelin Meng, Tianlai Wang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Heat shock protein gp96 drives natural killer cell maturation and anti-tumor immunity by counteracting Trim28 to stabilize Eomes
Yuxiu Xu, Xin Li, Fang Cheng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Embryonic macrophages support endocrine commitment during human pancreatic differentiation
Adriana Migliorini, Sabrina Ge, Michael Atkins, et al.
Cell stem cell (2024) Vol. 31, Iss. 11, pp. 1591-1611.e8
Closed Access | Times Cited: 4
Coordinated Priming of NKG2D Pathway by IL-15 Enhanced Functional Properties of Cytotoxic CD4+CD28− T Cells Expanded in Systemic Lupus Erythematosus
Tingting Wang, Laiyou Wei, Shuhui Meng, et al.
Inflammation (2023) Vol. 46, Iss. 5, pp. 1587-1601
Open Access | Times Cited: 10
A New Antibody–Cytokine Construct Targeting Natural Killer Cells: An Immunotherapeutic Approach to Chronic Lymphocytic Leukemia
Michela Flego, Mauro Andreotti, Francesca Romana Mauro, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 117-117
Open Access
The diversity of natural killer cell functional and phenotypic states in cancer
Kumar Rishabh, Sandro Matosevic
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top